 Connection
Yuki Fujiwara to Liver
This is a "connection" page, showing publications Yuki Fujiwara has written about Liver.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.361 |
|
|
|
-
Guo C, Toyomoto T, Tsutsuki H, Fujiwara Y, Komohara Y, Zhang T, Honda H, Lindahl S, Niidome T, Fang J, Xian M, Sawa T. Hepatic supersulfides attenuate acetaminophen-induced liver injury via enhanced detoxification and anti-inflammatory mechanisms. Redox Biol. 2026 05; 92:104140.
Score: 0.128
-
Kishimoto T, Nasu A, Uemura M, Kawano K, Ogasawara C, Fukuyama A, Nohara H, Nakashima R, Takahashi N, Fujiwara Y, Ikuta T, Suico MA, Kai H, Shuto T. Melinjo-derived Gnetin C restores metabolic balance via dual adipose and hepatic effects in high-fat diet mice. Sci Rep. 2025 Nov 25; 15(1):41801.
Score: 0.125
-
Halpern AL, Fitz JG, Fujiwara Y, Yi J, Anderson AL, Zhu Y, Schulick RD, El Kasmi KC, Barnett CC. Hepatic thermal injury promotes colorectal cancer engraftment in C57/black 6 mice. Am J Physiol Cell Physiol. 2021 01 01; 320(1):C142-C151.
Score: 0.088
-
Minayoshi Y, Maeda H, Yanagisawa H, Hamasaki K, Mizuta Y, Nishida K, Kinoshita R, Enoki Y, Imafuku T, Chuang VTG, Koga T, Fujiwara Y, Takeya M, Sonoda K, Wakayama T, Taguchi K, Ishima Y, Ishida T, Iwakiri Y, Tanaka M, Sasaki Y, Watanabe H, Otagiri M, Maruyama T. Development of Kupffer cell targeting type-I interferon for the treatment of hepatitis via inducing anti-inflammatory and immunomodulatory actions. Drug Deliv. 2018 Nov; 25(1):1067-1077.
Score: 0.019
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|